Microbiomes are a group of microorganisms living on a human body. They can be found on the skin, eyes, saliva, mouth, and digestive tract. Thousands of bacterial species/microbes as well as their genes, proteins, and metabolites are found in the human microbiome. Microbiome sequencing is the study and analysis of microbial groups found both outside and inside the human body to gain knowledge about human microbes. Microbiome sequencing and associated approaches are concerned with the investigation of the microbial composition of the human gut and its implications for health and disease development. This study can be useful in determining a patient's response to a specific treatment. Moreover, examining samples from human skin, stool, or blood was a labor-intensive and time-consuming operation that was followed by phenotypic or genotypic analysis in the early days. Microbiome sequencing services would aid in the commercialization of personalized medicine and diet if they were better understood and applied.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Owing to such factors, COVID 19 is expected to have a significant impact on the microbiome sequencing services market.
Top Impacting Factors
- Increase in demand for microbiome sequencing services for the diagnosis and early disease detection and growth in awareness about the use of the microbiome sequencing technology are expected to drive the growth of the of the market.
- Technological advancements in next-generation sequencing (NGS) can boost the growth of the market.
- In addition, increasing focus on human microbiome therapy as new validated target for drug development, rising investment in microbiome research, growing interest in understanding role of microbiome in human health are some factors driving the microbiome sequencing services market.
- Furthermore, increasing the incidence of colorectal cancer (CRC) globally can also increase the demand for the microbiome sequencing services. For instance, as per a 2019 report by the International Agency for Research on Cancer, the incidence of colon cancer is expected to increase from nearly 1.1 million in 2019 to over 1.5 million by 2030.
- Moreover, rise in the healthcare expenditure and the infrastructure can drives the growth of the microbiome sequencing services.
Market Trends
New Product Launches to Flourish the Market
In July 2020, Microba & Synlab inked an agreement to launch Microbiome Test in Europe and Latin America. The test measures bacterial species in the gut microbiome and calculates their metabolic potential in relation to healthy reference ranges. The product launch will bring its whole-genome metagenomic sequencing and bioinformatics software to new markets.
In January 2019, Clinical Microbiomics A/S offer full-service advanced microbiome analysis covering the entire workflow from extracting DNA, sequencing, profiling, and biostatistics linking the microbiome to relevant clinical parameters.
Surge in Usage of Microbiome Sequencing Services
Increase in usage of microbiome sequencing in genomics, proteomics, and metabolomics boosts the growth of the market. Increasing evidences that gut microbiota contributes to the carcinogenesis of colorectal cancer (CRC) along with genetic and other factors boost the usage of microbiome sequencing services. For instance, a 2020 report by Wanxin Liu et al., published in BioMed Research International Journal showed the role of gut microbiota in CRC in the Chinese population using 16SrRNA Sequencing.
Key Benefits of the Report
- This study presents the analytical depiction of the microbiome sequencing services market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Microbiome Sequencing Services Market Report
- Which are the leading market players active in the microbiome sequencing services market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What future projections would help in taking further strategic steps?
- What is microbiome sequencing services market?
- What is microbiome sequencing services market prediction in the future?
- Who are the leading global players in the microbiome sequencing services market?
- What are the current trends and predicted trends?
- What are the key benefits of the microbiome sequencing services market report?
Microbiome Sequencing Services Market Report Highlights
| Aspects | Details |
 By Technology |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Metabiomics Corp., MR DNA, Zymo Research Corp, Baseclear B.V., Microbiome Insights Inc, Microbiome Therapeutics, LLC, Merieux Nutrisciences Corporation, Ubiome, Inc., Clinical Microbiomics AS, Second Genome |
Loading Table Of Content...
